Related Experiment Video
Updated: Dec 20, 2025

05:59
Visualization of Intensity Levels to Reduce the Gap Between Self-Reported and Directly Measured Physical Activity
Published on: March 7, 2019
7.0K
Depression and Objectively Measured Physical Activity: A Systematic Review and Meta-Analysis
Vincenza Gianfredi1,2,3, Lorenzo Blandi2,4, Stefano Cacitti2,4
1School of Medicine, Vita-Salute San Raffaele University, 20132 Milan, Italy.
Summary
Regular physical activity (PA) significantly reduces the risk of developing and experiencing depression. This meta-analysis confirms PA
Area of Science:
- Epidemiology
- Mental Health
- Exercise Science
Background:
- Depression presents a substantial global health burden.
- Physical activity (PA) is explored for its potential protective role against depression.
- Existing evidence on PA and depression is inconsistent, possibly due to varied measurement methods.
Purpose of the Study:
- To systematically review and meta-analyze the association between objectively measured PA and depression.
- To evaluate the impact of PA on both incident (new cases) and prevalent (existing cases) depression.
Main Methods:
- Systematic review and meta-analysis adhering to Cochrane Collaboration and PRISMA guidelines.
- Comprehensive literature search across major databases (PubMed, Embase, PsycINFO, Scopus, WoS, Cochrane Library) up to August 31, 2019.
- Inclusion of 42 studies involving 37,408 participants for quantitative analysis.
Main Results:
- A significant protective effect of higher levels of PA against depression was observed.
- The overall effect size (ES) for depression between the highest and lowest PA groups was -1.16 (95% CI = -1.41; -0.91, p < 0.001).
- Objectively measured PA demonstrated a notable association with reduced depression prevalence and incidence.
Conclusions:
- Objectively measured physical activity demonstrates a significant protective effect against both prevalent and incident depression.
- Findings support the integration of PA interventions in mental health strategies to mitigate depression.
- Standardized measurement of PA is crucial for clarifying its role in mental well-being.
Related Concept Videos
Depression: Overview
662
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
662
Depressive Disorders: Etiology
353
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
353
Depressive Disorders: MDD and Dysthymia
446
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
446
Antidepressant Drugs: MAOIs and Other Agents
688
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
688
Long-term Depression
32.8K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
32.8K

